Reason for request
Radiation
Arrêt du remboursement suite à un arrêt de commercialisation.
Avis favorable à l’arrêt du remboursement de la spécialité IMBRUVICA (ibrutinib) 140 mg, gélule dans les indications de l’AMM.
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
wgkx2pfyT3VgW7g8
